NCT03591367View on ClinicalTrials.gov

The Potential Role Of MicroRNA-155 And Telomerase Reverse Transcriptase In Diagnosis Of Non-Muscle Invasive Bladder Cancer And Their Pathological Correlation

NACompletedINTERVENTIONAL
Enrollment

115

Participants

Timeline

Start Date

August 1, 2018

Primary Completion Date

May 1, 2019

Study Completion Date

May 1, 2019

Conditions
Bladder CancerBladder DiseaseBladder NeoplasmMicro-RNA
Interventions
DIAGNOSTIC_TEST

MicroRNAs-155

Quantitative analysis of cell-free miR-155 using RT-qPCR.

DIAGNOSTIC_TEST

Human telomerase reverse transcriptase

Analysis TERT by TERT messenger RNA (mRNA)expression by reverse transcription-quantitative polymerase chain reaction.

Trial Locations (1)

35516

Urology and Nephrology Center, Al Mansurah

All Listed Sponsors
lead

Mansoura University

OTHER

NCT03591367 - The Potential Role Of MicroRNA-155 And Telomerase Reverse Transcriptase In Diagnosis Of Non-Muscle Invasive Bladder Cancer And Their Pathological Correlation | Biotech Hunter | Biotech Hunter